Helix Biopharma Corp.
HBPCF
$1.73
$1.13188.97%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -93.99% | 0.15% | 1,437.46% | -86.15% | 27.40% |
| Total Receivables | 123.53% | -63.75% | -50.84% | -48.09% | -16.99% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.68% | -18.97% | 53.07% | -3.09% | 142.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -71.97% | -10.30% | 574.33% | -78.28% | 39.21% |
|
|
|||||
| Total Current Assets | -71.97% | -10.30% | 574.33% | -78.28% | 39.21% |
| Net Property, Plant & Equipment | -87.50% | -79.35% | -53.87% | -77.97% | -7.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1,898,085.71% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,160.40% | -12.35% | 502.53% | -78.22% | 37.79% |
|
|
|||||
| Total Accounts Payable | 168.84% | 62.60% | 921.25% | 0.07% | 65.15% |
| Total Accrued Expenses | -20.32% | 68.11% | 183.23% | 172.42% | 79.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 103.29% | 58.55% | 246.62% | 39.20% | -19.77% |
|
|
|||||
| Total Current Liabilities | 103.29% | 58.55% | 246.62% | 39.20% | -19.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 103.29% | 58.55% | 246.62% | 39.20% | -19.77% |
|
|
|||||
| Common Stock & APIC | 10.31% | 2.97% | -3.98% | 2.58% | -0.05% |
| Retained Earnings | -2.28% | -4.08% | 3.10% | -4.26% | 0.39% |
| Treasury Stock & Other | -16.85% | 53.70% | 77.55% | 40.51% | 1.61% |
| Total Common Equity | 17,373.01% | -284.08% | 93.23% | -318.58% | 89.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17,373.01% | -284.08% | 93.23% | -318.58% | 89.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17,373.01% | -284.08% | 93.23% | -318.58% | 89.85% |
|
|
|||||